Sponsor Pipeline

Shanghai Zhongshan Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
236
Active Trials
96
Recruiting
11
Phase 3
10
Disease Areas
17
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT07445061
Machine Learning Prediction of Mortality After Prone Positioning in ARDS
Completed without a posted recruiting period
2026-08-11 NCT07677410
Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients…
Recruitment opened
2026-08-11 NCT07694687
A Prospective Observational Study Using the FAM-CAM
Recruitment opened
2026-08-06 NCT07725484
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
date change Primary completion pushed: 2030-08-01 -> 2030-11-01
2026-08-06 NCT07725484
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
date change Completion pushed: 2030-10-01 -> 2030-12-01
2026-08-06 NCT07629921
Multimodal Al for Precision Diagnosis of Esophageal Cancer
critical Trial terminated
2026-08-06 NCT07629921
Multimodal Al for Precision Diagnosis of Esophageal Cancer
critical Trial terminated: local ethics review
2026-08-05 NCT07400601
A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at…
critical overall status: Recruiting → Withdrawn
2026-08-05 NCT07400601
A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at…
critical Trial withdrawn: The Principal Investigator believes that the study protocol requires major amendments and a redesign, and therefore with...
2026-08-05 NCT07400601
A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at…
Enrollment reduced: 6000 -> 0 participants
2026-08-05 NCT07649382
A Novel Strategy for Endoscopic Dual-instrument Retrieval of Upper GI Foreign Body
Sponsor refiled this as active, not recruiting (was completed)
2026-08-02 NCT06530784
Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma
overall status: Not Yet Recruiting → Unknown
2026-08-02 NCT06530667
Broadband Collaborative Pulse Ablation Instrument Treating Malignant Pulmonary Nodules
overall status: Not Yet Recruiting → Unknown
2026-08-02 NCT06521515
Lung Ultrasound Morphology Patterns Predict Weaning Outcomes
overall status: Recruiting → Unknown
2026-08-02 NCT05389527
Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma
overall status: Active, Not Recruiting → Unknown
2026-08-02 NCT04483284
Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients
overall status: Active, Not Recruiting → Unknown
2026-08-02 NCT04220944
Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.
overall status: Active, Not Recruiting → Unknown
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-10 NCT07756086 Accuracy of 3D Electrical Impedance Tomography for Assessing Lung Ventilation Not Yet Recruiting
2026-07-29 NCT07733076 LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement Not Yet Recruiting
2026-07-29 NCT07733115 QL1706(Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line… Phase 2 Recruiting
2026-07-29 NCT07733843 Impact of 3D-EIT-Guided Acapella Breathing Training on Lung Ventilation Distribution Not Yet Recruiting
2026-07-29 NCT07734857 Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in… Not Yet Recruiting
2026-07-27 NCT07727317 Evaluate the Diagnostic Efficacy and Safety of INR 202 PET/CT Imaging in Participants… Not Yet Recruiting
2026-07-24 NCT07724951 The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC… Not Yet Recruiting
2026-07-24 NCT07725484 Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients Phase 3 Not Yet Recruiting
2026-07-20 NCT07714317 Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 4
14
Phase 3
6
Phase 2/3
5
Phase 2
49
Phase 1/2
5
Phase 1
4
Early Phase 1
9
Not specified
144
Active Trials — top 25 of 236
NCT IDTitleConditionStatus
Phase 4
NCT04300686 A Pilot Study in Severe Patients With Takayasu Arteritis. Takayasu Arteritis Recruiting
NCT05102448 Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis Takayasu Arteritis Recruiting
NCT06498089 A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy… Takayasu Arteritis Recruiting
NCT06725810 Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease Chronic Kidney Disease Associated Anemia Recruiting
NCT07272512 Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced… Neuroendocrine Tumors Recruiting
NCT06451198 IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly… Coronary Artery Disease Recruiting
NCT07172451 Gelaspan vs Crystalloid Therapy in Sepsis Sepsis Recruiting
NCT07307235 Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China… Type 2 Diabetes Recruiting
NCT06863363 PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults Non-diabetic Obesity Not Yet Recruiting
NCT07156656 Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection Type A Aortic Dissection Not Yet Recruiting
NCT07325357 Effect of Pirfenidone on TA Fibrosis Takayasu Arteritis Not Yet Recruiting
NCT07405684 Fecal Molecular Susceptibility-guided Hp First-line Therapy HELICOBACTER PYLORI INFECTIONS Not Yet Recruiting
NCT07405697 Fecal Molecular Susceptibility-guided Hp Rescue Therapy Helicobacter Pylori Infection Not Yet Recruiting
NCT07621380 Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction Type 2 Diabetes Mellitus Myocardial Infarction Not Yet Recruiting
Phase 3
NCT07309289 NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line… Metastatic Colorectal Cancer (CRC) Recruiting
NCT07320625 Efficacy of Montelukast on STEMl Patients Myocardial Infarction (MI) Recruiting
NCT07231523 EFG vs IVIG in TAMG Efgartigimod Not Yet Recruiting
NCT07479784 Octreotide Microspheres for Preventing Pancreatic Fistula Pancreatic Fistula Not Yet Recruiting
NCT07508956 Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant… Gastric / Gastroesophageal Junction Adenocarcinoma Not Yet Recruiting
NCT07725484 Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients Heart Failure Due to Coronary Artery Disease Not Yet Recruiting
Phase 2/3
NCT04973306 Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable… Esophageal Squamous Cell Carcinoma Stage II Recruiting
NCT06796803 Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC)… Potentially Resectable Hepatocellular Carcinoma Recruiting
NCT04521153 Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable… Hepatocellular Carcinoma Active, Not Recruiting
NCT04669496 Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX… Intrahepatic Cholangiocarcinoma Active, Not Recruiting
NCT07309419 A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus… Hepatocellular Carcinoma Not Yet Recruiting
See all 236 active Shanghai Zhongshan Hospital trials with filters →
Disease Areas
Get alerts when Shanghai Zhongshan Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free